The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Mon., Mar. 2, 6:12 AM

Slide #3. Transgenomic Secondary Offering

Company: Transgenomic (NASDAQ:TBIO)
Date announced: 2/26/2015
Shares Offered: 3,573,899
Date of Pricing: 2/27/2015
Price Per Share: $1.73
Secondary Offering Details: Transgenomic, Inc. (NASDAQ:TBIO) today announced that it intends to offer shares of the company's common stock and corresponding warrants to purchase shares of the company's common stock in an underwritten public offering. Craig-Hallum Capital Group LLC is acting as the sole managing underwriter of the offering. - updated 2/27 - Transgenomic, Inc. (NASDAQ:TBIO) today announced the pricing of an underwritten public offering of 3,573,899 shares of the company's common stock and corresponding warrants to purchase 714,780 shares of the company's common stock. After the underwriting discount and estimated offering expenses payable by the company, Transgenomic expects to receive net proceeds of approximately $6.2 million. The offering is expected to close on or about March 4, 2015, subject to customary closing conditions.

Transgenomic is a biotechnology company. Co. has three segments: clinical laboratories, which is engaged in genetic testing for cardiology, neurology, mitochondrial disorders, and oncology; pharmacogenomics services, which focuses on pharmacogenomic, biomarker and mutation discovery research serving the pharmaceutical and biomedical industries for disease research, drug and diagnostic development and clinical trial support; and diagnostic tools, which includes its WAVE® System for genetic variation detection in both molecular genetic research and molecular diagnostics, the distribution of bioinstruments produced by other manufacturers, and consumable products such as SURVEYOR® Nuclease.
Open the TBIO Page at The Online Investor »

Company Name:  Transgenomic Inc
Website:  www.transgenomic.com
Sector:  Biotechnology
 

Open the TBIO Page at The Online Investor (in a new window) »

March 2, 2015    6:12 AM Eastern
Quotes delayed 20 minutes


Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.